Mount Sinai Alzheimer’s Researcher Wins Rainwater Prize for Outstanding Innovation in Neurodegenerative Research
Recognizes scientist’s contribution to understanding tau-related diseases
The Rainwater Charitable Foundation has named Alison M. Goate, DPhil, the Jean C. and James W. Crystal Professor and Chair of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, as this year’s winner of the Rainwater Prize for Outstanding Innovation in Neurodegenerative Research. The prize recognizes Dr. Goate’s “significant contribution to our understanding of tau-related diseases,” such as Alzheimer’s disease and frontotemporal dementia.
“It is an honor to be recognized by the Rainwater Charitable Foundation,” said Dr. Goate. “The Rainwater Foundation has played an important role in bringing a variety of scientists together to combat the devastation wrought by tau-related brain diseases, which affect millions of patients and their loved ones.”
Tau-related brain diseases, or tauopathies, are a group of neurodegenerative disorders that are associated with the appearance of abnormal versions of tau proteins in neural tissue.
Dr. Goate is a pioneer in the field of dementia research. Studies in her lab have led to the discovery that certain mutations in genes called APP, PSEN1, and MAPT are linked to some inherited forms of Alzheimer’s disease and frontotemporal dementia. Currently, her lab uses advanced cell and molecular techniques to investigate how genomic risk factors may cause the neural damage seen in tauopathies.
The Rainwater Prize Program aims to “foster scientific discovery by elevating awareness of the gaps in neurodegenerative research, bringing new researchers into the tauopathy field, and awarding scientific achievements that could lead to innovative, effective treatments.” Dr. Goate received her prize of $250,000 on Wednesday, February 23, at the virtual conference Global Tau 2022, hosted by the Rainwater Charitable Trust and the Alzheimer’s Association.
Dr. Goate will be honored along with Martin Kampmann, PhD, Associate Professor for Neurodegenerative Diseases at the University of California, San Francisco, who will receive the Rainwater Prize for Innovative Early-Career Scientist. Both were chosen by their peers and “were selected based on their research, leadership, mentorship, and positive impact within the scientific community.”
"The Rainwater Charitable Foundation is grateful for the opportunity to honor Dr. Goate and Dr. Kampmann for their groundbreaking and highly collaborative efforts in the neurodegenerative disease field," said Amy Rommel, PhD, Scientific Program Director for the Rainwater Charitable Foundation. "It is no surprise that these two world-renowned investigators happen to also be close collaborators, who have published together and are working on several ongoing important programs collectively.”
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.